THE EFFECT OF TAILORED ANTIPLATELET THERAPEUTIC STRATEGY DURING PERCUTANEOUS CORONARY INTERVENTION ON PERIPROCEDURAL MYONECROSIS IN DIABETIC PATIENTS: INSIGHTS FROM THE DM-VERIFYNOW STUDY

Diabetic patients show poor response to antiplatelet agents and are prone to periprocedural complications during percutaneous coronary intervention (PCI) compared to non-diabetic patients. In this study, we investigated the effect of tailored antiplatelet strategy on the periprocedural ischemic